Chell Jeffrey W.
SEC insider (Form 3/4/5 filer). CIK 0001738374. Director at Actinium Pharmaceuticals, Inc. (ATNM). 8 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in NEW YORK, NY.
Companies Chell Jeffrey W. has filed insider reports for
- Actinium Pharmaceuticals, Inc. (ATNM): Director
Chell Jeffrey W.
CIK: 0001738374
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Actinium Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 2, 2026ATNM
Actinium Pharmaceuticals, Inc.
AwardDirect61.6K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
2.5K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
2.5K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
8.3K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
8.3K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
18.4K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
72.2K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
70.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | Award | 61,600 | - | $0 | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 2,500 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 2,500 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 8,333 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 8,333 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 18,351 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 72,156 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 70,311 | - | - | Direct |
1-8 of 8 transactions